Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
pemigatinib fibroblast growth factor receptor 1 small molecule Successful target TTD , drugbank , DGIDB Cholangiocarcinoma[MeSHID:D018281]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Syndrome[MeSHID:D013577]
Malignant neoplasm of urinary bladder[MeSHID:D001749]		 0.71 approved,investigational inhibitor
pemigatinib fibroblast growth factor receptor 2 small molecule Successful target TTD , drugbank , DGIDB Cholangiocarcinoma[MeSHID:D018281]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Syndrome[MeSHID:D013577]
Malignant neoplasm of urinary bladder[MeSHID:D001749]		 2.08 approved,investigational inhibitor
pemigatinib fibroblast growth factor receptor 2 small molecule Successful target TTD , drugbank , DGIDB Cholangiocarcinoma[MeSHID:D018281]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Syndrome[MeSHID:D013577]
Malignant neoplasm of urinary bladder[MeSHID:D001749]		 2.08 approved,investigational inhibitor,activator
pemigatinib fibroblast growth factor receptor 3 small molecule Successful target TTD , drugbank , DGIDB Cholangiocarcinoma[MeSHID:D018281]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Syndrome[MeSHID:D013577]
Malignant neoplasm of urinary bladder[MeSHID:D001749]		 1.03 approved,investigational inhibitor
pemigatinib fibroblast growth factor receptor 4 small molecule NA drugbank Cholangiocarcinoma[MeSHID:D018281]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Syndrome[MeSHID:D013577]
Malignant neoplasm of urinary bladder[MeSHID:D001749]		 NA approved,investigational inhibitor
click here to return to the previous page